Evidence map›Paper›PMID 40307452›Full record

ArticleNature immunology2025

Stepwise neofunctionalization of the NF-κB family member Rel during vertebrate evolution.

Allison E Daly, Abraham B Chang, Prabhat K Purbey, Kevin J Williams, Shuxing Li, Benjamin D Redelings, George Yeh, Yongqing Wu, Scott D Pope, Byrappa Venkatesh and 8 more

Abstract read
In one paragraph

Article in Nature immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Examining NF-κB genomic interactions by ChIP-seq and CUT&Tag.bioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Allison E Daly *Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-7030-8663
Abraham B Chang *Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA.
Prabhat K Purbey *Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-6373-6283
Kevin J Williams *Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA.
Shuxing LiDepartment of Biological Sciences, University of Southern California, Los Angeles, CA, USA.
Benjamin D RedelingsDepartment of Ecology and Evolutionary Biology, University of Kansas, Lawrence, KS, USA.
George YehDepartment of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA.
Yongqing WuDepartment of Biological Sciences, University of Southern California, Los Angeles, CA, USA.
Scott D PopeDepartment of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-5243-3639
Byrappa VenkateshComparative Genomics Lab, Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research, Singapore, Singapore.
Sibon LiDepartment of Human Genetics, UCLA, Los Angeles, CA, USA.
Kaylin NguyenDepartment of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA.
Joseph RodriguesDepartment of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA.
Kelsey JorgensenDepartment of Anthropology, University of Kansas, Lawrence, KS, USA.ORCID http://orcid.org/0000-0002-8681-5248
Ananya DasguptaDepartment of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA.
Trevor SiggersDepartment of Biology, Boston University, Boston, MA, USA.ORCID http://orcid.org/0000-0002-8039-7639
Lin ChenDepartment of Biological Sciences, University of Southern California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0003-4798-6199
Stephen T SmaleDepartment of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA. smale@mednet.ucla.edu.ORCID http://orcid.org/0000-0002-9835-6907

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
UCLA Tumor Immunology Training ProgramT32CA009120 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Steven M. Dubinett, MICHAEL A TEITELL · 1985 to 2026
$10.3M
MULTIDISCIPLINARY TRAINING IN MICROBIAL PATHOGENESIST32AI007323 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Peter John Bradley · 1988 to 2026
$8.6M
Vitamin D Metabolism in LeprosyP50AR063020 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ADAMS, JOHN S · 2012 to 2016
$7.8M
Selective Regulation of Pro-Inflammatory Genes in MacrophagesR01GM086372 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SMALE, STEPHEN T · 2008 to 2015
$2.5M
Selective gene activation by the NF-kappaB family of transcription factorsR01AI073868 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SMALE, STEPHEN T · 2007 to 2011
$1.8M
Pro-inflammatory gene regulation in a native chromatin environmentR01CA127279 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SMALE, STEPHEN T · 2008 to 2011
$1.2M
Mechanistically defining the role for each NFkB family member in pro-inflammatory macrophage activationF31AI157267 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DALY, ALLISON E · 2021 to 2022
$78k
Howard Hughes Medical Institute (HHMI) NoneNCI NIH HHS P30 CA016042NCI NIH HHS R01 CA127279NCI NIH HHS T32 CA009120NIAID NIH HHS F31 AI157267NIAID NIH HHS R01 AI073868NIAID NIH HHS T32 AI007323NIAMS NIH HHS P50 AR063020NIGMS NIH HHS R01 GM086372U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA127279U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) T32CA009120U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) F31AI157267U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI073868U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) T32AI007323U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P50AR063020U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R01GM086372
6 · The paper itself

Abstract

Adaptive immunity and the five vertebrate NF-κB family members first emerged in cartilaginous fish, suggesting that NF-κB family divergence helped to facilitate adaptive immunity. One specialized function of the NF-κB Rel protein in macrophages is activation of Il12b, which encodes a key regulator of T cell development. We found that Il12b exhibits much greater Rel dependence than inducible innate immunity genes in macrophages, with the unique function of Rel dimers depending on a heightened intrinsic DNA-binding affinity. Chromatin immunoprecipitation followed by sequencing experiments defined differential DNA-binding preferences of NF-κB family members genome-wide, and X-ray crystallography revealed a key residue that supports the heightened DNA-binding affinity of Rel dimers. Unexpectedly, this residue, the heightened affinity of Rel dimers, and the portion of the Il12b promoter bound by Rel dimers were largely restricted to mammals. Our findings reveal major structural transitions in an NF-κB family member and one of its key target promoters at a late stage of vertebrate evolution that apparently contributed to immunoregulatory rewiring in mammalian species.

Indexed as

Evolution, MolecularInterleukin-12 Subunit p40MacrophagesNF-kappa BProto-Oncogene Proteins c-relVertebratesAdaptive ImmunityAnimalsCrystallography, X-RayHumansImmunity, InnateMicePromoter Regions, GeneticProtein BindingProtein MultimerizationInterleukin-12 Subunit p40NF-kappa BProto-Oncogene Proteins c-rel

Identifiers

PMID40307452
PMCPMC12043515

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.